micro-community-banner
 
  • Saved
Sex, Gender, and COPD - PubMed

Sex, Gender, and COPD - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/39586033/

Sex and gender have emerged as critical considerations relevant to chronic obstructive pulmonary disease (COPD). Sex differences in lung development and physiologic response to hormones and environmental exposures influence COPD...

Sex and gender influence COPD susceptibility, progression, and outcomes through differences in lung development, hormones, immunity, and exposures. Emerging omics highlight divergent molecular pathways, underscoring gaps in understanding sex-specific COPD biology.

  • Saved

This study identified pathogen patterns and significant drug resistance among hospitalized AECOPD patients, highlighting predominant gram-negative bacteria, fungal involvement, and high resistance to common antibiotics.

  • Saved
Sarcopenia in Chronic Obstructive Pulmonary Disease - PubMed

Sarcopenia in Chronic Obstructive Pulmonary Disease - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/41247691/

Chronic obstructive pulmonary disease, Sarcopenia, Inflammation, Muscle mass.

The study found sarcopenia highly prevalent in COPD, especially GOLD Group E, with reduced handgrip strength and functional measures, underscoring the need for routine assessment and targeted rehabilitation.

  • Saved
Understanding the bidirectional relationship between chronic respiratory disease and cardiovascular disease using genetic evidence - PubMed

Understanding the bidirectional relationship between chronic respiratory disease and cardiovascular disease using genetic evidence - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/41241414/

While we found limited genetic evidence linking CRD and CVD, smoking and inflammatory markers commonly affect both. These findings highlight the complexity of CRD-CVD comorbidities, whose pathophysiology likely does not...

Genetic analyses showed limited direct causal links between chronic respiratory and cardiovascular diseases. Smoking and inflammatory pathways strongly influenced risks across both conditions, highlighting shared mechanisms rather than bidirectional disease causation.

  • Saved
Advances in lung health and sleep medicine: Key highlights from CHEST 2025

At CHEST 2025 in Chicago, pulmonology experts shared new insights in asthma, COPD, interstitial lung disease, pulmonary hypertension, and sleep medicine. Dr. Sandhya Khurana highlighted emerging asthma data—such as imaging-based reductions in mucus plugging and outcomes in severe asthma with nasal polyps—while also discussing the future of nanobody therapeutics. Dr. Cosmo Fowler reviewed GLP-1 RA–linked survival benefits in OSA.

Share your thoughts